Journal article
Direct oral anticoagulants for stroke prevention in patients with device-detected atrial fibrillation: assessing net clinical benefit
Abstract
Subclinical, device-detected atrial fibrillation (AF) is frequently recorded by pacemakers and other implanted cardiac rhythm devices. Patients with device-detected AF have an elevated risk of stroke, but a lower risk of stroke than similar patients with clinical AF captured with surface electrocardiogram. Two randomized clinical trials (NOAH-AFNET 6 and ARTESiA) have tested a direct oral anticoagulant (DOAC) against aspirin or placebo. A …
Authors
McIntyre WF; Benz AP; Tojaga N; Brandes A; Lopes RD; Healey JS
Journal
European Heart Journal Supplements, Vol. 26, No. Supplement_4, pp. iv4–iv11
Publisher
Oxford University Press (OUP)
Publication Date
August 1, 2024
DOI
10.1093/eurheartjsupp/suae075
ISSN
1520-765X